Menu

Belite Bio, Inc (BLTE) Q3 2026 Earnings Call Transcript
📰

Belite Bio, Inc (BLTE) Q3 2026 Earnings Call Transcript

All Articles on Seeking Alpha·6 days ago
#ugMkUuoZ
#seekingalpha#call#research#belite#julie
Reading 0:00
15s threshold

Belite Bio, Inc ( BLTE ) Q3 2026 Earnings Call November 12, 2026 4:30 PM EST

Company Participants

Julie Fallon

Yu-Hsin Lin - Chairman of the Board of Directors & CEO

Hao-Yuan Chuang - CFO & Director

Hendrik Scholl - Chief Medical Officer

Conference Call Participants

Maxwell Skor - Morgan Stanley, Research Division

Tazeen Ahmad - BofA Securities, Research Division

Steven Seedhouse - Cantor Fitzgerald & Co., Research Division

Marc Goodman - Leerink Partners LLC, Research Division

Whitney Ijem - Canaccord Genuity Corp., Research Division

Graig Suvannavejh - Mizuho Securities USA LLC, Research Division

Presentation

Operator

Ladies and gentlemen, thank you for joining us, and welcome to the Belite Bio Third Quarter 2026 Earnings Call. [Operator Instructions]

I will now hand the conference over to Julie Fallon. Please go ahead.

Julie Fallon

Good afternoon. Thank you for joining us today. On the call are Dr. Tom Lin, Chairman and CEO of Belite Bio; Dr. Hendrik Scholl, Chief Medical Officer; Dr.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.